Published in Physician Law Weekly, October 13th, 2004
According to recent research from Australia, "A 'cocaine vaccine' is a promising immunotherapeutic approach to treating cocaine dependence which induces the immune system to form antibodies that prevent cocaine from crossing the blood brain barrier to act on receptor sites in the brain. Studies in rats show that cocaine antibodies block cocaine from reaching the brain and prevent the reinstatement of cocaine self-administration. A successful phase 1 trial of a human cocaine vaccine has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly